Biogen, Inc. (BIIB)
251.40
+0.61
(+0.24%)
USD |
NASDAQ |
Nov 18, 16:00
251.40
0.00 (0.00%)
After-Hours: 19:29
Biogen Total Return Level : 250.79 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 250.79 |
| November 16, 2026 | 251.65 |
| November 13, 2026 | 253.40 |
| November 12, 2026 | 250.48 |
| November 11, 2026 | 253.40 |
| November 10, 2026 | 253.25 |
| November 09, 2026 | 254.87 |
| November 06, 2026 | 248.35 |
| November 05, 2026 | 243.93 |
| November 04, 2026 | 254.46 |
| November 03, 2026 | 248.93 |
| November 02, 2026 | 249.01 |
| October 30, 2026 | 253.62 |
| October 29, 2026 | 249.65 |
| October 28, 2026 | 244.05 |
| October 27, 2026 | 252.73 |
| October 26, 2026 | 252.26 |
| October 23, 2026 | 250.69 |
| October 22, 2026 | 253.84 |
| October 21, 2026 | 240.98 |
| October 20, 2026 | 243.10 |
| October 19, 2026 | 233.48 |
| October 16, 2026 | 232.65 |
| October 15, 2026 | 235.35 |
| October 14, 2026 | 232.83 |
| Date | Value |
|---|---|
| October 13, 2026 | 228.90 |
| October 12, 2026 | 229.41 |
| October 09, 2026 | 225.71 |
| October 08, 2026 | 218.43 |
| October 07, 2026 | 222.15 |
| October 06, 2026 | 222.89 |
| October 05, 2026 | 223.59 |
| October 02, 2026 | 219.88 |
| October 01, 2026 | 222.82 |
| September 30, 2026 | 225.88 |
| September 29, 2026 | 227.07 |
| September 28, 2026 | 228.69 |
| September 25, 2026 | 227.60 |
| September 24, 2026 | 226.36 |
| September 23, 2026 | 227.53 |
| September 22, 2026 | 225.36 |
| September 21, 2026 | 219.07 |
| September 18, 2026 | 215.50 |
| September 17, 2026 | 219.05 |
| September 16, 2026 | 216.01 |
| September 15, 2026 | 216.17 |
| September 14, 2026 | 217.36 |
| September 11, 2026 | 217.15 |
| September 10, 2026 | 215.43 |
| September 09, 2026 | 210.73 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Gilead Sciences, Inc. | 249.53 |
| AbbVie, Inc. | 507.46 |
| Amgen, Inc. | 685.72 |
| Eli Lilly & Co. | 3744.66 |
| Regeneron Pharmaceuticals, Inc. | 966.64 |